ASRT vs KO · rev $125.0M vs P/E 25, rev $47.94B
Assertio Therapeutics Inc (ASRT) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
ASRT currently screens at market cap $151.5M. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the ASRT and KO stock pages for the full models.
Not investment advice.